City State Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.23M Sell
2,696
-188
-7% -$192K 0.74% 38
2026
Q1
$2.65M Sell
2,884
-12
-0.4% -$12.2K 0.69% 39
2025
Q4
$3.11M Sell
2,896
-157
-5% -$150K 0.85% 32
2025
Q3
$2.33M Sell
3,053
-100
-3% -$74.4K 0.67% 35
2025
Q2
$2.46M Buy
3,153
+2
+0.1% +$1.55K 0.77% 30
2025
Q1
$2.6M Sell
3,151
-135
-4% -$112K 0.86% 26
2024
Q4
$2.54M Buy
3,286
+159
+5% +$132K 0.89% 26
2024
Q3
$2.77M Sell
3,127
-102
-3% -$91.7K 1.01% 22
2024
Q2
$2.92M Sell
3,229
-16
-0.5% -$12.8K 1.19% 19
2024
Q1
$2.52M Sell
3,245
-203
-6% -$144K 1.11% 20
2023
Q4
$2.01M Sell
3,448
-145
-4% -$84.6K 1.01% 20
2023
Q3
$1.93M Sell
3,593
-175
-5% -$90.2K 1.06% 22
2023
Q2
$1.77M Sell
3,768
-23
-0.6% -$9.65K 0.95% 23
2023
Q1
$1.3M Sell
3,791
-120
-3% -$40.5K 0.74% 31
2022
Q4
$1.43M Sell
3,911
-386
-9% -$137K 0.88% 26
2022
Q3
$1.39M Sell
4,297
-43
-1% -$13.6K 0.97% 23
2022
Q2
$1.41M Buy
4,340
+25
+0.6% +$7.5K 0.98% 20
2022
Q1
$1.24M Buy
4,315
+57
+1% +$14.7K 0.75% 28
2021
Q4
$1.18M Buy
+4,258
New +$1.08M 0.72% 33

Other funds holding LLY

City State Bank's LLY Position: Q2 2026 in Review

City State Bank reduced its Eli Lilly (LLY) stake by 6.5% in Q2 2026, selling an estimated $192K and leaving 2,696 shares worth $3.23M. The position accounts for 0.74% of the portfolio, ranked #38.

City State Bank first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • City State Bank held 2,696 shares of Eli Lilly worth $3.23M as of Q2 2026.
  • City State Bank sold 188 Eli Lilly shares in Q2 2026, an estimated $192K.
  • Eli Lilly made up 0.74% of City State Bank's portfolio in Q2 2026, its #38 holding.
  • City State Bank first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.